Skip to main content
Earnings Labs
Oculis Holding AG logo

Oculis Holding AG (OCS)

NASDAQ·Healthcare·Biotechnology

$12.01

+1.01%

Mkt Cap $646.59M

Analyst Ratings

Buy

13

Hold

0

Sell

0

Price Target (13 analysts)

$39.40

Range $26.00$50.00

Implied Upside

+228.1%

Consensus $39.40 vs current $12.01